Cancer Research and Biostatistics

Analysis

Cancer Research and Biostatistics is a registered charity in United States, based in Seattle, WA. It received its IRS tax-exemption ruling in April 1998, 28 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Cancer Research and Biostatistics reported income of $12.1m and spending of $12.5m, spending 104% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $12.8m to $12.1m (-5.5%), an average of -1.4% a year. Over the whole period it spent 98% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Cancer Research and Biostatistics sits at the 85th percentile: it is larger than about 85% of them. Against every charity in United States with reported income it ranks in the 96th percentile, and in the 96th percentile within WA. Charities of a similar size with the same main cause include Corewell Health ($12.1m), Seattle Drug & Narcotic Center Seadruner ($12.1m) and Jefferson Comprehensive Care System Inc ($12.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 70% and program service revenue 28% of the total. Compensation of current officers, directors and key employees was $1.2m (9.4% of expenses). Other salaries and wages came to $6.3m. At year end it held assets of $11.5m against liabilities of $5.8m, net assets of $5.7m. It reported 87 employees.